Experimental animals
The study was conducted after the approval of the Institutional Animal Ethical and Research Committee (No.318/VPY/MVC/PG Edn./2017). Thirty-two client-owned dogs (22 males and 10 females) irrespective of sex and breed, brought to the Madras Veterinary College Teaching Hospital with clinical signs commensurate with babesiosis like pyrexia, pale and congested mucous membrane, ecchymosis, petechial haemorrhages, melena, haematuria and lymphadenopathy were screened for infection by the semi-nested PCR after getting consent from the owners for the inclusion of their dogs in the study and confirmed to have
Babesia infection. The age ranged from 12 to 96 months (median = 54 months). There were 4 German shepherds, 12 Labrador retrievers, 10 mixed breeds, 2 Spitz’s, 2 Dobermans and 2 Great danes. The weight ranged from 18 to 52 kg (median = 35 kg). All the infected dogs were followed up during the treatment period for their survivability and they were classified into survivors (n=18) and non-survivors (n=14) of infection. The control group included 32 healthy, client-owned dogs presented for a routine general health check-up. Clinical examination, peripheral blood smear evaluation, CBC, biochemistry profile, PCR were done in control dogs to rule out infection. Dogs in the control group were age and breed matched with infected groups.
B. vogeli infected animals were treated with diminazene aceturate (Berenil® Vet 7% RTU; MSD Animal Health) 3.5 mg/kg IM single dose and dogs with
B. gibsoni and dual infection of
B. vogeli and
B. gibsoni received clindamycin (Clindapet, Vea Impex, Mumbai, India) 30 mg/kg PO q12h, diminazene aceturate (Berenil® Vet 7% RTU; MSD Animal Health) 3.5 mg/kg IM once on the day of treatment start, imidocarb diproprionate (Imicarb, Vea Impex, Mumbai, India) 6 mg/kg SC once on the day after diminazene aceturate (Berenil® Vet 7% RTU; MSD Animal Health) is administered. Also, treatment for the complications was applied at the discretion of the clinician.
Sample collection
All the blood samples were collected on the first day of admission to the hospital before treatment and they were used immediately for analysis. Blood samples were collected aseptically from each dog by venepuncture of the saphenous vein in vacutainers with EDTA as an anticoagulant for DNA isolation to perform PCR and in clot activator tube for isolation of serum and further biochemical analysis.
Screening for Babesia infection
Molecular detection of
Babesia infection was done by using DNA isolated from whole blood of all the animals (QIAamp DNA Mini Kit®, Qiagen, Hilden, Germany). After assessing the purity and concentration of the extracted DNA, semi-nested PCR was done for species identification of
Babesia infection. Genus and species-specific primers for the PCR study were selected according to
Birkenheuer et al., (2003) (Table 1). The primary PCR for identification of
the Babesia genus was performed in a 20 µl reaction volume containing 10 µl of Taq 2x Master Mix RED 1.5 mMmgCl2 (Ampliqon, Denmark), 10 pmol each of forward and reverse primers, 2.0 µl of template DNA. The amplification program was done in a thermocycler (T100TM Thermal Cycler, Bio-Rad, USA) with initial denaturation at 94°C for 5 min followed by 35 cycles of denaturation at 94°C for 45 s, annealing at 59°C for 45 s and extension at 72°C for 45 s and a final extension at 72°C for 5 min.
The amplicons of primary PCR were subjected to secondary PCR for species confirmation. The cyclical condition for the secondary PCR was similar to that of primary PCR except for the annealing temperature (60°C for 45 s), reaction cycle (30) and 2.0 µl amplicon of primary PCR as DNA template. The amplicons were resolved by electrophoresis on 2% agarose gel stained with ethidium bromide (0.4µg/ml) using 100 base pair ladder (Thermo Scientific, Lithuania). The results were visualized and captured using a gel imager (Gel DocTM XR+ Molecular imager®, Bio-Rad, Bio-Rad Laboratories, India).
Assessment of oxidative stress
To detect the presence of oxidative stress, the concentration of serum antioxidant enzymes like catalase, glutathione peroxidase 1, superoxide dismutase were measured by solid sandwich immunoassay using the canine-specific ELISA kit (Sincere Biotech, Beijing-101300, China). Lipid peroxidation was determined as thiobarbituric acid reactive substance using the canine-specific ELISA kit (Sincere Biotech, Beijing-101300, China). The serum concentration of antioxidant micro minerals like zinc, selenium and copper was estimated by the atomic absorption spectrophotometer (PinnAAcle900H, PerkinElmer Health Science Pvt. Ltd. India). Concentrations of zinc and copper were estimated by air acetylene flame method using a hollow cathode lamp at the wavelength of 213.86 nm and 324.75 nm respectively. The concentration of selenium was estimated by the graphite furnace method using an electrodeless discharge lamp at the wavelength of 196.03 nm. Standard concentration (linear plot) of zinc, copper and selenium used in measurements were 0 to 1.5 ppm, 0 to 2 ppm and 0 to 80 ppm respectively.
Assessment of acute-phase response and hepcidin concentration
Serum C-reactive protein concentration was measured by using a commercial C-reactive protein assay kit (Sincere Biotech, Beijing-101300, China). The concentration of serum amyloid A and serum hepcidin were determined with a canine-specific solid sandwich immunoassay (Sincere Biotech, Beijing-101300, China). The final absorbance of samples was measured at 450 nm (Epoch Microplate Spectrophotometer, BioTek Instruments, Inc., USA).
Assessment of systemic iron status
Serum iron, TIBC and UIBC were estimated by ferrozine method using the colorimetric kit (Coral clinical systems, Goa, India). Low haemoglobin density, an indicator of functional iron availability was identified by the mathematical sigmoid transformation of mean cell haemoglobin concentration of all the animals using the formula described by
Urrechaga (2010).
LHD% = 100 × √1- [1/(1+ e1.8(30-MCHC))]
Statistical analysis
Normality of data was assessed by Shapiro-Wilk test. One-way analysis of variance followed by pair-wise comparisons using the Tukey’s test was used to determine the significant variation among control, survivor and non-survivors of infection and also among three different disease groups. Pearson’s correlation was performed to assess the association between hepcidin and other parameters. Receiver operating characteristics curve analysis was used to determine the use of hepcidin as a prognostic marker to discriminate the survivability of dogs with canine babesiosis. P<0.05 was considered statistically significant. All analyses were performed using a commercial statistics program (SPSS IBM Version 23 software, IBM Statistics, Armonk, NY, USA).